
TYME TECHNOLOGIESLOGIES INC
Action · US90238J1034 · TYME · A14XMS (XNCM)
Pas de cours
n/a
Performance
Jour | Semaine | Mois | 3 mois | 6 mois | 1 an | 5 ans |
---|---|---|---|---|---|---|
- | - | - | - | 0,00 % | 0,00 % | -79,42 % |
Profil de l'entreprise pour TYME TECHNOLOGIESLOGIES INC Action
Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also developing TYME-19, an oral synthetic member of the bile acid family, which is in preclinical stage for the treatment of SARS CoV-2 diseases; and TYME-18, a CMBT compound that is in preclinical stage for the treatment of inoperable tumors. It has research collaborations with Mayo Clinic to perform in-depth analysis of pancreatic cancer cell gene expression, epigenetic, and metabolism changes from SM-88 treatment; and a research investigator at Georgetown University to examine the effects of SM-88 in breast cancer. The company was formerly known as Global Group Enterprises Corp. The company was incorporated in 2011 and is headquartered in Bedminster, New Jersey. As of September 16, 2022, Tyme Technologies, Inc. operates as a subsidiary of Syros Pharmaceuticals, Inc.
Données de l'entreprise
Nom TYME TECHNOLOGIESLOGIES INC
Société Tyme Technologies, Inc.
Symbole TYME
Site web
https://www.tymeinc.com
Marché d'origine
NASDAQ CAPITAL MARKET
WKN A14XMS
ISIN US90238J1034
Type de titre Action
Secteur Healthcare
Industrie Biotechnology
PDG Mr. Steven E. Hoffman
Pays États-Unis d'Amérique
Devise USD
Employés 0,0 T
Adresse 17 State St Fl 7, 07921 New York City
Date d'introduction en bourse 2012-05-25
Symboles boursiers
Nom | Symbole |
---|---|
NASDAQ | TYME |
Autres actions
Les investisseurs qui détiennent TYME TECHNOLOGIESLOGIES INC ont également les actions suivantes dans leur portefeuille :
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles.
Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.